| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $125.6M | +20.9% |
| R&D Expense | $17.9M | -10.8% |
| SG&A Expense | $28.3M | +12.6% |
| Operating Income | $24.8M | +79.5% |
| Pre-tax Income | $26.1M | +86.2% |
| Income Tax | $2.0M | +863.0% |
| Net Income | $24.0M | +68.5% |
| EPS (Basic) | $0.43 | +72.0% |
| EPS (Diluted) | $0.42 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.4M | -24.2% |
| Short-term Investments | $33.5M | +6.9% |
| Accounts Receivable | $34.1M | +65.2% |
| Inventory | $28.4M | +39.2% |
| Current Assets | $157.9M | +4.0% |
| Total Assets | $217.0M | +1.6% |
| Current Liabilities | $18.3M | -7.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.6M | -6.6% |
| Capital Expenditures | $4.2M | -36.6% |
| Investing Cash Flow | -$6.9M | +66.2% |
| Financing Cash Flow | -$23.7M | -85.0% |
| Free Cash Flow | $8.4M | +22.7% |
| +75.0% |
| Total Liabilities |
| $31.7M |
| -9.2% |
| Stockholders' Equity | $185.3M | +3.7% |